Disruption of the SUMOylation machinery has been shown to be sufficient to restore TGM2 homeostasis in CF cell lines providing a theoretical basis for the use of SUMOylation inhibitors in the treatment of CF-associated lung infections. The gene discussed is TGM2; the disease is cystic fibrosis.